Will T2 Biosystems Inc (TTOO) Beat the Rest of the Stocks in the Healthcare Sector?

Monday, August 10, 2020 10:48 AM | InvestorsObserver Analysts

A rating of 95 puts T2 Biosystems Inc (TTOO) near the top of the Healthcare sector according to InvestorsObserver.

T2 Biosystems Inc's score of 95 means that it ranks higher than 95% of stocks in the sector. In addition, its overall score of 69 ranks it higher than 69% of all stocks.

Overall Score - 69
TTOO has an Overall Score of 69. Find out what this means to you and get the rest of the rankings on TTOO!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 69 means the stock is more attractive than 69 percent of stocks.

Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score.

The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With T2 Biosystems Inc Stock Today?

T2 Biosystems Inc (TTOO) stock is trading at $1.92 as of 10:45 AM on Monday, Aug 10, a rise of $0.22, or 12.94% from the previous closing price of $1.70. The stock has traded between $1.72 and $1.97 so far today. Volume today is light. So far 11,782,844 shares have traded compared to average volume of 16,361,541 shares.

To screen for more stocks like TTOO click here.

Share this article:

Related Companies

Upgrade to Premium and Analyze Stocks Like a Pro

50% Off All Subscriptions
InvestorsObserver Premium
InvestorsObserver Premium
InvestorsObserver Premium
Save up to 65% with annual

InvestorsObserver Premium

$ 20.75 $ 10.38 /month
$249 $124.50 billed annually

You May Also Like

Related Articles

Midday Report: Wall Street Recovers, Still Heading for Fourth Week of Losses

Wall Street Recovers Midday, Still Heading for Fourth Week of Losses

What do the Fundamentals Predict for Koninklijke Philips NV (PHG) Stock?

The Ensign Group, Inc. (ENSG) Stock: How Does it Score on Valuation Metrics?

Do Traders View Fulcrum Therapeutics Inc (FULC) Stock's Current Trend Positively?

Should You Buy GlaxoSmithKline plc (GSK) Stock After it Is Lower By 4.43% in a Week?

Related Companies